Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continued Access Protocol For Convergence Of Epicardial And Endocardial RF Ablation For The Treatment Of Symptomatic Persistent AF CONVERGE CAP Study

NCT04239534 is registered in ClinicalTrials.gov with AtriCure, Inc. as lead sponsor.

NCT NCT04239534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04239534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continued Access Protocol For Convergence Of Epicardial And Endocardial RF Ablation For The Treatment Of Symptomatic Persistent AF CONVERGE CAP Study
Lead sponsor
AtriCure, Inc.
Phase
Not applicable
Overall status
Withdrawn
Start date
December 31, 2021
Completion date
November 30, 2026
Enrollment
0 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation